Case Report

A Family with Von Hippel-Lindau Syndrome: The Findings of Indium-111 Somatostatin Receptor Scintigraphy, Iodine-123 Metaiodobenzylguanidine Scintigraphy and Single Photon Emission Computerized Tomography
  • Pelin Arıcan
  • Berna Okudan Tekin
  • Seniha Naldöken
  • Rıza Şefizade
  • Dilek Berker
Mol Imaging Radionucl Ther 2017; 26: 38-42 DOI: 10.4274/mirt.70894 PMID:28291009
Visualization of Gallbladder with In-111 Octreotide Scan
  • Filiz Özülker
  • Tamer Özülker
  • M. Tarık Tatoğlu
  • Aysun Küçüköz Uzun
Mol Imaging Radionucl Ther 2015; 24: 87-89 DOI: 10.4274/mirt.07108 PMID:26316475
Uptake Difference by Somatostatin Receptors in a Patient with Neuroendocrine Tumor: 99mTc-Octreotide Uptake in the Lung without Uptake in Liver Lesions
  • Elahe Pirayesh
  • Mahasti Amoui
  • Majid Assadi
Mol Imaging Radionucl Ther 2015; 24: 128-131 DOI: 10.4274/mirt.02996 PMID:27529888
An Incidental Solitary Plasmacytoma of Bone Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography
  • Duygu Has Şimşek
  • Serkan Kuyumcu
  • Bilge Bilgiç
  • Emine Göknur Işık
  • Cüneyt Türkmen
  • Işık Adalet
Mol Imaging Radionucl Ther 2016; 25: 147-149 DOI: 10.4274/mirt.93064 PMID:27751979

Original Article

Physiological Biodistribution of 68Ga-DOTA-TATE in Normal Subjects
  • Salih Özgüven
  • Nuh Filizoğlu
  • Selin Kesim
  • Kevser Öksüzoğlu
  • Feyza Şen
  • Tunç Öneş
  • Sabahat İnanır
  • Halil Turgut Turoğlu
  • Tanju Yusuf Erdil
Mol Imaging Radionucl Ther 2021; 30: 39-46 DOI: 10.4274/mirt.galenos.2021.37268 PMID:33586406
Initial Findings on the Use of [225Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors
  • Emre Demirci
  • Nalan Alan Selçuk
  • Gamze Beydağı
  • Meltem Ocak
  • Türkay Toklu
  • Kaan Akçay
  • Levent Kabasakal
Mol Imaging Radionucl Ther 2023; 32: 226-232 DOI: 10.4274/mirt.galenos.2023.38258 PMID:37870290

Original Articles

The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours
  • Emel Koçyigit Deveci
  • Meltem Ocak
  • Murat Fani Bozkurt
  • Selcan Türker
  • Levent Kabasakal
  • Ömer Ugur
Mol Imaging Radionucl Ther 2013; 22: 76-84 DOI: 10.4274/Mirt.68552 PMID:24416622
Improved Benefit of SPECT/CT Compared to SPECT Alone for the Accurate Localization of Endocrine and Neuroendocrine Tumors
  • Gonca G. Bural
  • Ashok Muthukrishnan
  • Matthew J. Oborski
  • James M. Mountz
Mol Imaging Radionucl Ther 2012; 21: 91-96 DOI: 10.4274/Mirt.80299 PMID:23487541

Interesting Image

Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action
  • Majid Assadi
  • Seyed Javad Rekabpour
  • Abdullatif Amini
  • Habibollah Dadgar
  • Reza Nemati
  • Ali Gholamrezanezhad
  • Iraj Nabipour
  • Esmail Jafari
  • Hojjat Ahmadzadehfar
Mol Imaging Radionucl Ther 2021; 30: 107-109 DOI: 10.4274/mirt.galenos.2020.69783 PMID:34082512
Almost Complete Response with a Single Administration 225Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary
  • Nalan Alan Selçuk
  • Emre Demirci
  • Meltem Ocak
  • Türkay Toklu
  • Selçuk Ergen
  • Levent Kabasakal
Mol Imaging Radionucl Ther 2022; 31: 139-141 DOI: 10.4274/mirt.galenos.2022.64497 PMID:35771003